ARCHIVES

NCCTG Plans To Conduct Phase II Study Of Brostallicin Plus Cisplatin For mTNBC

This article is from The Cancer Letter archive.

Vol. 33 No. 4 | April 30, 2010

Download PDF Visit The Full Archive

Related Articles

Funding opportunities listed.

April 16, 2004

Control AC Hear Report On High Risk conference, Messer Survey

September 6, 1974

ODAC Endorses Tamoxifen Trial, With Modification to Ensure Enrollment of Women At Higher Risk

August 2, 1991

Obit: J. Gale Katterhagen, NCAB’s First Community Physician.

May 4, 2001

Broder; Cancer Act’s Special Authorities Don’t Give Director Immunity For NIH, HHS

September 27, 1991

High-Dose Chemo Doesn’t Improve Survival In Small Cell Lung Cancer

April 25, 2008